A detailed history of Iam Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Iam Advisory, LLC holds 16,614 shares of NVO stock, worth $1.82 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
16,614
Previous 16,845 1.37%
Holding current value
$1.82 Million
Previous $2.4 Million 17.72%
% of portfolio
0.5%
Previous 0.65%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$119.07 - $145.42 $27,505 - $33,592
-231 Reduced 1.37%
16,614 $1.98 Million
Q2 2024

Jul 12, 2024

BUY
$122.71 - $146.91 $11,780 - $14,103
96 Added 0.57%
16,845 $2.4 Million
Q1 2024

Apr 15, 2024

BUY
$102.11 - $135.92 $28,897 - $38,465
283 Added 1.72%
16,749 $2.15 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $36,340 - $43,656
414 Added 2.58%
16,466 $1.7 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $1.46 Million - $3.2 Million
16,052 New
16,052 $1.46 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $248B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Iam Advisory, LLC Portfolio

Follow Iam Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iam Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iam Advisory, LLC with notifications on news.